Irhythm Technologies (IRTC) Set to Announce Earnings on Wednesday

Irhythm Technologies (NASDAQ:IRTC) is set to release its earnings data after the market closes on Wednesday, February 14th. Analysts expect Irhythm Technologies to post earnings of ($0.35) per share for the quarter.

Irhythm Technologies (IRTC) opened at $57.92 on Wednesday. The company has a quick ratio of 7.57, a current ratio of 7.65 and a debt-to-equity ratio of 0.38. The company has a market cap of $1,340.74, a price-to-earnings ratio of -48.67 and a beta of 1.56. Irhythm Technologies has a one year low of $32.10 and a one year high of $66.20.

In other Irhythm Technologies news, CFO Matthew C. Garrett sold 1,193 shares of the business’s stock in a transaction on Monday, December 4th. The shares were sold at an average price of $55.00, for a total transaction of $65,615.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Matthew C. Garrett sold 42,910 shares of the business’s stock in a transaction on Friday, January 5th. The shares were sold at an average price of $59.17, for a total transaction of $2,538,984.70. Following the transaction, the chief financial officer now directly owns 36,085 shares in the company, valued at $2,135,149.45. The disclosure for this sale can be found here. Over the last three months, insiders have sold 476,533 shares of company stock worth $25,222,506. Insiders own 23.30% of the company’s stock.

A number of research analysts have issued reports on IRTC shares. Royal Bank of Canada started coverage on shares of Irhythm Technologies in a research report on Monday, December 4th. They set an “outperform” rating and a $79.00 price objective on the stock. Zacks Investment Research downgraded shares of Irhythm Technologies from a “hold” rating to a “sell” rating in a research report on Wednesday, January 3rd. BidaskClub raised shares of Irhythm Technologies from a “hold” rating to a “buy” rating in a research report on Friday, January 5th. Canaccord Genuity reissued a “buy” rating and set a $59.00 price objective on shares of Irhythm Technologies in a research report on Tuesday, November 14th. Finally, Morgan Stanley boosted their price objective on shares of Irhythm Technologies from $50.00 to $65.00 and gave the company an “overweight” rating in a research report on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $65.25.

ILLEGAL ACTIVITY WARNING: “Irhythm Technologies (IRTC) Set to Announce Earnings on Wednesday” was originally reported by American Banking News and is the property of of American Banking News. If you are reading this piece on another domain, it was illegally stolen and republished in violation of US and international copyright legislation. The original version of this piece can be accessed at https://www.americanbankingnews.com/2018/02/07/irhythm-technologies-irtc-set-to-announce-earnings-on-wednesday.html.

About Irhythm Technologies

iRhythm Technologies, Inc is a United States-based digital health company. The Company develops and commercializes solutions that integrate biosensor technology, patient data, analytics and medical expertise. The Company offers flagship solution, the ZIO Service. Its ZIO Service consists of the ZIO XT Patch, algorithms and the ZIO Report.

Earnings History for Irhythm Technologies (NASDAQ:IRTC)

Receive News & Ratings for Irhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Irhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply